Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 10% – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN)’s share price traded up 10% during mid-day trading on Wednesday . The stock traded as high as $26.17 and last traded at $25.85. 7,355 shares were traded during trading, a decline of 89% from the average session volume of 68,845 shares. The stock had previously closed at $23.50.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

Anbio Biotechnology Trading Up 10.3%

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, December 30th. The company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.